Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke
- 1 September 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 42 (9) , 2633-2635
Abstract
Background and Purpose—: Plasma matrix metalloproteinase-9 levels predict posttissue plasminogen activator (tPA) hemorrhage. Methods—: The authors investigated the effect of minocycline on plasma matrix metalloproteinase-9 in acute ischemic stroke in the Minocycline to Improve Neurological Outcome in Stroke (MINOS) trial and a comparison group. Results—: Matrix metalloproteinase-9 level decreased at 72 hours compared with baseline in MINOS (tPA, P =0.0022; non-tPA, P =0.0066) and was lower than in the non-MINOS comparison group at 24 hours (tPA, P P =0.0019). Conclusions—: Lower plasma matrix metalloproteinase-9 was seen among tPA-treated subjects in the MINOS trial. Combining minocycline with tPA may prevent the adverse consequences of thrombolytic therapy through suppression of matrix metalloproteinase-9 activity.Keywords
This publication has 9 references indexed in Scilit:
- Minocycline to Improve Neurologic Outcome in Stroke (MINOS)Stroke, 2010
- Extension of the Thrombolytic Time Window With Minocycline in Experimental StrokeStroke, 2008
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Association between tPA therapy and raised early matrix metalloproteinase-9 in acute strokeNeurology, 2006
- Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activatorNature Medicine, 2003
- Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human StrokeCirculation, 2003
- Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral IschemiaThe Journal of Neuroscience, 2001
- Matrix Metalloproteinase Expression After Human Cardioembolic StrokeStroke, 2001
- Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in RatsStroke, 1998